WAG
APLT

Windsor Advisory Group’s Applied Therapeutics APLT Stock Holding History

Windsor Advisory Group’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-416,757
Closed -$357K – 54
2024
Q4 		$357K Buy
416,757
+217,770
+109% +$1.37M 0.41% 39
2024
Q3 		$1.69M Buy
+198,987
New +$1.17M 1.91% 12

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Windsor Advisory Group's APLT Position: Q1 2025 in Review

Windsor Advisory Group sold out of Applied Therapeutics (APLT) in Q1 2025, closing a stake of 416,757 shares — an estimated $357K sold.

Windsor Advisory Group first reported a position in APLT in Q3 2024 and held it in 2 quarters. The position peaked at $1.69M in Q3 2024. 89 funds tracked by Wall St. Rank hold APLT as of Q1 2025.

  • Windsor Advisory Group reported no remaining Applied Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Windsor Advisory Group sold 416,757 Applied Therapeutics shares in Q1 2025, an estimated $357K.
  • Windsor Advisory Group first reported a position in Applied Therapeutics in Q3 2024 and held it in 2 quarters.
  • Windsor Advisory Group's Applied Therapeutics position peaked at $1.69M in Q3 2024.
  • 89 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2025.

Based on Windsor Advisory Group's 13F filing for Q1 2025, filed 15 May 2025.